Author

Andrea Antinori

Director HIV/AIDS Unit - INMI - National Institute for Infectious Diseases L. Spallanzani, Roma - Cited by 42,888 - infectious diseases - virology - HIV

Biography

Dr.Andrea Antinori Graduated in Medicine at University of Milan (1984).  Post-degree specialization in Infectious Diseases at the Catholic University, Rome (1987).From August 1987 until February 1993, Clinical Assistant in Infectious Diseases at the Infectious Diseases Department of Catholic University of Rome. From March 1993 until June 1999,  Assistant Professor at the Infectious Diseases Department of the Catholic University, Rome. From February 1999 up to now, Head of Division of Infectious Diseases, National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS in Rome, and from December 1999 up to now, Director of the Clinical Department in the same Institute. 
Title
Cited by
Year
Immunological signature in human cases of monkeypox infection in 2022 outbreak: an observational study
C Agrati, A Cossarizza, V Mazzotta, G Grassi, R Casetti, S De Biasi, ...The Lancet Infectious Diseases 23 (3), 320-0, 2023202
33
2023
Monkeypox virus in human body sites and fluids: evidence for transmission
F Colavita, A Antinori, E Nicastri, D Focosi, E Girardi, F Vaia, F MaggiThe Lancet Infectious Diseases 23 (1), 6-8, 2023202
13
2023
Clinical experience with use of oral Tecovirimat or Intravenous Cidofovir for the treatment of Monkeypox in an Italian reference hospital
A Mondi, R Gagliardini, V Mazzotta, S Vita, F Carletti, C Pinnetti, ...Journal of Infection 86 (1), 66-117, 2023202
10
2023
Viral load decrease in SARS‐CoV‐2 BA. 1 and BA. 2 Omicron sublineages infection after treatment with monoclonal antibodies and direct antiviral agents
V Mazzotta, A Cozzi Lepri, F Colavita, S Rosati, E Lalle, C Cimaglia, ...Journal of Medical Virology 95 (1), e216, 2023202
8
2023
Genomic surveillance of SARS-CoV-2 positive passengers on flights from China to Italy, December 2022
F Novazzi, E Giombini, M Rueca, A Baj, L Fabeni, A Genoni, FD Ferrante, ...Eurosurveillance 28 (2), 2300008, 2023202
7
2023
Virological efficacy of switch to DTG plus 3TC in a retrospective observational cohort of suppressed HIV-1 patients with or without past M184V: the LAMRES study
MM Santoro, D Armenia, E Teyssou, JR Santos, C Charpentier, ...Journal of Global Antimicrobial Resistance 31, 2-62, 2022202
5
2022
The possible effect of sociobehavioral factors and public health actions on the mpox epidemic slowdown
F Vairo, S Leone, V Mazzotta, P Piselli, G De Carli, S Lanini, F Maggi, ...International Journal of Infectious Diseases 130, 83-85, 2023202
4
2023
Proteomic analysis identifies a signature of disease severity in the plasma of COVID-19 pneumonia patients associated to neutrophil, platelet and complement activation
F Ciccosanti, M Antonioli, A Sacchi, S Notari, A Farina, A Beccacece, ...Clinical Proteomics 19 (1), 1-15, 2022202
4
2022
SARS-CoV-2 nasopharyngeal viral load in individuals infected with BA. 2, compared to Alpha, Gamma, Delta and BA. 1 variants: A single-center comparative analysis
I Mastrorosa, A Cozzi-Lepri, F Colavita, E Lalle, V Mazzotta, C Cimaglia, ...Journal of Clinical Virology 157, 105299, 2022202
4
2022
Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA study
A D’arminio Monforte, A Tavelli, M Sala, A Mondi, S Rusconi, S Antinori, ...Journal of Antimicrobial Chemotherapy 78 (4), 9-945, 20220
3
2023
Hepatitis delta coinfection in persons with HIV: misdiagnosis and disease burden in Italy
G Brancaccio, M Shanyinde, M Puoti, GB Gaeta, ADA Monforte, A Vergori, ...Pathogens and Global Health 117 (2), 181-189, 20220
3
2023
Declining Prevalence of Human Immunodeficiency Virus (HIV)–Associated Neurocognitive Disorders in Recent Years and Associated Factors in a Large Cohort of Antiretroviral …
I Mastrorosa, C Pinnetti, AC Brita, A Mondi, P Lorenzini, G Del Duca, ...Clinical Infectious Diseases 76 (), e629-e67, 20220
3
2023
Monkeypox Virus Infection across 16 Countries-April-June 2022. Reply.
JP Thornhill, A Antinori, CM OrkinThe New England Journal of Medicine 87 (25), e69-e69, 2022202
3
2022
Kinetics of viral DNA in body fluids and antibody response in patients with acute Monkeypox virus infection
F Colavita, V Mazzotta, G Rozera, I Abbate, F Carletti, C Pinnetti, ...Iscience 6 (3), 030
2
2023
What is the impact of post-COVID-19 syndrome on health-related quality of life and associated factors: a cross-sectional analysis
What is the impact of post-COVID-9 syndrome on health-related quality of life and associated factors: a cross-sectional analysisI Mastrorosa, G Del Duca, C Pinnetti, P Lorenzini, A Vergori, AC Brita, ...Health and Quality of Life Outcomes 2 (), 28, 2023202
1
2023
Comparison of SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples from Patients Infected with Omicron Variant
L Bordi, G Sberna, E Lalle, L Fabeni, V Mazzotta, S Lanini, A Corpolongo, ...International journal of molecular sciences 24 (5), 4847, 2023202
1
2023
Real world efficacy of dolutegravir plus lamivudine in people living with HIV with undetectable viral load after previous failures
R Gagliardini, P Lorenzini, A Cozzi-Lepri, A Tavelli, V Borghi, L Galli, ...Journal of Global Antimicrobial Resistance 32, 58-63, 2023202
1
2023
Efficacy and Safety of Anticoagulant Therapy in COVID-19-Related Pulmonary Embolism with Different Extension
Efficacy and Safety of Anticoagulant Therapy in COVID-9-Related Pulmonary Embolism with Different ExtensionMC Gatto, A Oliva, C Palazzolo, C Picariello, A Garascia, E Nicastri, ...Biomedicines (5), 282, 2023202
1
2023
Tecovirimat concentrations and viral suppression in seminal fluid from patients with mpox
M Tempestilli, A Mondi, G Matusali, D Mariotti, C Pinnetti, A Beccacece, ...The Lancet Infectious Diseases 23 (5), 53-532, 2023202
1
2023
Awareness and perception of accuracy of the Undetectable= Untransmittable message (U= U) in Italy: results from a survey among PLWHA, infectious-diseases physicians and people …
A Cingolani, A Tavelli, GV Calvino, F Maggiolo, E Girardi, A Cozzi-Lepri, ...AIDS care 35 (6), 923-933, 2023202
1
2023

Referred From: https://scholar.google.com/citations?hl=it&user=Z46Z9LAAAAAJ

Cited by
Citations 42888
h-index 95
i10-index 498
Recommended Journals
Open Access Journals